W

Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871

Watchlist Manager
Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871
Watchlist
Price: 11.71 CNY -0.26% Market Closed
Market Cap: 1.9B CNY
Have any thoughts about
Wuhan Hvsen Biotechnology Co Ltd?
Write Note

Wuhan Hvsen Biotechnology Co Ltd
Income to Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Wuhan Hvsen Biotechnology Co Ltd
Income to Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income to Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
W
Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871
Income to Minority Interest
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Income to Minority Interest
-ÂĄ25.4m
CAGR 3-Years
16%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Income to Minority Interest
ÂĄ5.1m
CAGR 3-Years
-35%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Income to Minority Interest
-ÂĄ32.7m
CAGR 3-Years
-228%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Wuhan Hvsen Biotechnology Co Ltd
Glance View

Market Cap
1.9B CNY
Industry
Pharmaceuticals

HVSEN Biotechnology Co., Ltd. engages in the research and development, production, and sale of veterinary drugs. The company is headquartered in Wuhan, Hubei and currently employs 828 full-time employees. The company went IPO on 2020-08-24. The Company’s main products include veterinary active pharmaceutical ingredients, veterinary chemical preparations, veterinary traditional Chinese medicine preparations, feed and additives and environmental improvers, such as tyvanicin tartrate, florfenicol powder, banqing granules and piglet composites pre-mixed feed, etc. The firm mainly conducts its businesses in the China market.

Intrinsic Value
22.35 CNY
Undervaluation 48%
Intrinsic Value
Price
W

See Also

What is Wuhan Hvsen Biotechnology Co Ltd's Income to Minority Interest?
Income to Minority Interest
0 CNY

Based on the financial report for Dec 31, 2023, Wuhan Hvsen Biotechnology Co Ltd's Income to Minority Interest amounts to 0 CNY.

Back to Top